NCT02606630 [11C]-PBR28 Positron Emission Tomography Study to Evaluate the Effect of ABT 555 in Subjects With Relapsing Forms of Multiple Sclerosis Status TERMINATED Phase PHASE1
NCT02604017 A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Subjects With Genotype 1 Infection Status COMPLETED Phase PHASE3
NCT02601885 A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis Status COMPLETED Phase PHASE1
NCT02598570 Study Evaluating Duvelisib in Japanese Subjects With Relapsed or Refractory Lymphoma Status COMPLETED Phase PHASE1
NCT02596217 Safety, Tolerability and Pharmacokinetics of BI 655066/ABBV-066 (Risankizumab) in Healthy Asian and Caucasian Male Volunteers Status COMPLETED Phase PHASE1
NCT02590263 Study Evaluating ABT-414 in Japanese Subjects With Malignant Glioma Status COMPLETED Phase PHASE1/PHASE2
NCT02582671 The Effectiveness of ABT-450/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C -An Observational Study in Ireland Status COMPLETED Phase N/A
NCT02582658 Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Austria (REAL) Status COMPLETED Phase N/A
NCT02582632 A Study to Evaluate Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Treatment-Naïve Hepatitis C Virus Genotype 1b-Infected Adults Status COMPLETED Phase PHASE3
NCT02581202 The Effectiveness of Dual Therapy (Lopinavir/Ritonavir + LamivudinE) in Treatment-Experienced HIV Infected Patients in the Russian Federation Status COMPLETED Phase N/A
NCT02581189 Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in Canada Status COMPLETED Phase N/A
NCT02581163 Effectiveness of Paritaprevir/Ritonavir - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Belgium Status COMPLETED Phase N/A
NCT02581020 The Durability of Response and Persistence of Resistance to AbbVie's 2 Direct-acting Antiviral Agent (2D) Therapy in Japanese Subjects Status COMPLETED Phase N/A
NCT02578238 Post-Marketing Surveillance of Humira in Korean Pediatric Crohn's Disease (CD) Patients Under the "New-Drug Re-examination" Status COMPLETED Phase N/A
NCT02573740 Safety, Tolerability and the Effects on Cerebrospinal Fluid Spectrin Breakdown Product-145 Levels of ABT-957 in Subjects With Mild Alzheimer's Disease and Mild Cognitive Impairment Status TERMINATED Phase PHASE1
NCT02573324 A Study of ABT-414 in Participants With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification Status COMPLETED Phase PHASE3
NCT02565758 ABBV-085, an Antibody Drug Conjugate, in Subjects With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02556736 AGN-151597 (Formerly RST-001) Phase I/II Trial for Advanced Retinitis Pigmentosa Status COMPLETED Phase PHASE1/PHASE2
NCT02549092 A Study to Examine the Effect of Levodopa-Carbidopa Intestinal Gel (LCIG) Therapy Relative to That of Optimized Medical Treatment (OMT) on Non-motor Symptoms (NMS) Associated With Advanced Parkinson's Disease (PD) Status COMPLETED Phase PHASE3
NCT02539849 Effect of Prebiotic FOS on Intestinal Abundance of Faecalibacterium Prausnitzii in Patients With Crohn´s Disease Status COMPLETED Phase NA